Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Filgrastim Injection Market Growth 2022-2028

  • LP 4887150
  • 96 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Filgrastim Injection will have significant change from previous year. According to our (LP Information) latest study, the global Filgrastim Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Filgrastim Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Filgrastim Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Filgrastim Injection market, reaching US$ million by the year 2028. As for the Europe Filgrastim Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Filgrastim Injection players cover Accord Healthcare, Teva Pharmaceuticals, Pfizer, and Amgen Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Filgrastim Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

300mcg/mL (vial)

480mcg/1.6 mL (vial)

300mcg/0.5mL (Prefilled Syringe)

480mcg/0.8mL (Prefilled Syringe)

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Adult Use

Pediatric Use

Geriatric Use

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Accord Healthcare

Teva Pharmaceuticals

Pfizer

Amgen Inc

Novartis AG

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Filgrastim Injection Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Filgrastim Injection by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Filgrastim Injection by Country/Region, 2017, 2022 & 2028

2.2 Filgrastim Injection Segment by Type

2.2.1 300mcg/mL (vial)

2.2.2 480mcg/1.6 mL (vial)

2.2.3 300mcg/0.5mL (Prefilled Syringe)

2.2.4 480mcg/0.8mL (Prefilled Syringe)

2.3 Filgrastim Injection Sales by Type

2.3.1 Global Filgrastim Injection Sales Market Share by Type (2017-2022)

2.3.2 Global Filgrastim Injection Revenue and Market Share by Type (2017-2022)

2.3.3 Global Filgrastim Injection Sale Price by Type (2017-2022)

2.4 Filgrastim Injection Segment by Application

2.4.1 Adult Use

2.4.2 Pediatric Use

2.4.3 Geriatric Use

2.5 Filgrastim Injection Sales by Application

2.5.1 Global Filgrastim Injection Sale Market Share by Application (2017-2022)

2.5.2 Global Filgrastim Injection Revenue and Market Share by Application (2017-2022)

2.5.3 Global Filgrastim Injection Sale Price by Application (2017-2022)

3 Global Filgrastim Injection by Company

3.1 Global Filgrastim Injection Breakdown Data by Company

3.1.1 Global Filgrastim Injection Annual Sales by Company (2020-2022)

3.1.2 Global Filgrastim Injection Sales Market Share by Company (2020-2022)

3.2 Global Filgrastim Injection Annual Revenue by Company (2020-2022)

3.2.1 Global Filgrastim Injection Revenue by Company (2020-2022)

3.2.2 Global Filgrastim Injection Revenue Market Share by Company (2020-2022)

3.3 Global Filgrastim Injection Sale Price by Company

3.4 Key Manufacturers Filgrastim Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Filgrastim Injection Product Location Distribution

3.4.2 Players Filgrastim Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Filgrastim Injection by Geographic Region

4.1 World Historic Filgrastim Injection Market Size by Geographic Region (2017-2022)

4.1.1 Global Filgrastim Injection Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Filgrastim Injection Annual Revenue by Geographic Region

4.2 World Historic Filgrastim Injection Market Size by Country/Region (2017-2022)

4.2.1 Global Filgrastim Injection Annual Sales by Country/Region (2017-2022)

4.2.2 Global Filgrastim Injection Annual Revenue by Country/Region

4.3 Americas Filgrastim Injection Sales Growth

4.4 APAC Filgrastim Injection Sales Growth

4.5 Europe Filgrastim Injection Sales Growth

4.6 Middle East & Africa Filgrastim Injection Sales Growth

5 Americas

5.1 Americas Filgrastim Injection Sales by Country

5.1.1 Americas Filgrastim Injection Sales by Country (2017-2022)

5.1.2 Americas Filgrastim Injection Revenue by Country (2017-2022)

5.2 Americas Filgrastim Injection Sales by Type

5.3 Americas Filgrastim Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Filgrastim Injection Sales by Region

6.1.1 APAC Filgrastim Injection Sales by Region (2017-2022)

6.1.2 APAC Filgrastim Injection Revenue by Region (2017-2022)

6.2 APAC Filgrastim Injection Sales by Type

6.3 APAC Filgrastim Injection Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Filgrastim Injection by Country

7.1.1 Europe Filgrastim Injection Sales by Country (2017-2022)

7.1.2 Europe Filgrastim Injection Revenue by Country (2017-2022)

7.2 Europe Filgrastim Injection Sales by Type

7.3 Europe Filgrastim Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Filgrastim Injection by Country

8.1.1 Middle East & Africa Filgrastim Injection Sales by Country (2017-2022)

8.1.2 Middle East & Africa Filgrastim Injection Revenue by Country (2017-2022)

8.2 Middle East & Africa Filgrastim Injection Sales by Type

8.3 Middle East & Africa Filgrastim Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Filgrastim Injection

10.3 Manufacturing Process Analysis of Filgrastim Injection

10.4 Industry Chain Structure of Filgrastim Injection

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Filgrastim Injection Distributors

11.3 Filgrastim Injection Customer

12 World Forecast Review for Filgrastim Injection by Geographic Region

12.1 Global Filgrastim Injection Market Size Forecast by Region

12.1.1 Global Filgrastim Injection Forecast by Region (2023-2028)

12.1.2 Global Filgrastim Injection Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Filgrastim Injection Forecast by Type

12.7 Global Filgrastim Injection Forecast by Application

13 Key Players Analysis

13.1 Accord Healthcare

13.1.1 Accord Healthcare Company Information

13.1.2 Accord Healthcare Filgrastim Injection Product Offered

13.1.3 Accord Healthcare Filgrastim Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Accord Healthcare Main Business Overview

13.1.5 Accord Healthcare Latest Developments

13.2 Teva Pharmaceuticals

13.2.1 Teva Pharmaceuticals Company Information

13.2.2 Teva Pharmaceuticals Filgrastim Injection Product Offered

13.2.3 Teva Pharmaceuticals Filgrastim Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Teva Pharmaceuticals Main Business Overview

13.2.5 Teva Pharmaceuticals Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Filgrastim Injection Product Offered

13.3.3 Pfizer Filgrastim Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Amgen Inc

13.4.1 Amgen Inc Company Information

13.4.2 Amgen Inc Filgrastim Injection Product Offered

13.4.3 Amgen Inc Filgrastim Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amgen Inc Main Business Overview

13.4.5 Amgen Inc Latest Developments

13.5 Novartis AG

13.5.1 Novartis AG Company Information

13.5.2 Novartis AG Filgrastim Injection Product Offered

13.5.3 Novartis AG Filgrastim Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novartis AG Main Business Overview

13.5.5 Novartis AG Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Filgrastim Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Filgrastim Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 300mcg/mL (vial)

Table 4. Major Players of 480mcg/1.6 mL (vial)

Table 5. Major Players of 300mcg/0.5mL (Prefilled Syringe)

Table 6. Major Players of 480mcg/0.8mL (Prefilled Syringe)

Table 7. Global Filgrastim Injection Sales by Type (2017-2022) & (KL)

Table 8. Global Filgrastim Injection Sales Market Share by Type (2017-2022)

Table 9. Global Filgrastim Injection Revenue by Type (2017-2022) & ($ million)

Table 10. Global Filgrastim Injection Revenue Market Share by Type (2017-2022)

Table 11. Global Filgrastim Injection Sale Price by Type (2017-2022) & (US$/L)

Table 12. Global Filgrastim Injection Sales by Application (2017-2022) & (KL)

Table 13. Global Filgrastim Injection Sales Market Share by Application (2017-2022)

Table 14. Global Filgrastim Injection Revenue by Application (2017-2022)

Table 15. Global Filgrastim Injection Revenue Market Share by Application (2017-2022)

Table 16. Global Filgrastim Injection Sale Price by Application (2017-2022) & (US$/L)

Table 17. Global Filgrastim Injection Sales by Company (2020-2022) & (KL)

Table 18. Global Filgrastim Injection Sales Market Share by Company (2020-2022)

Table 19. Global Filgrastim Injection Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Filgrastim Injection Revenue Market Share by Company (2020-2022)

Table 21. Global Filgrastim Injection Sale Price by Company (2020-2022) & (US$/L)

Table 22. Key Manufacturers Filgrastim Injection Producing Area Distribution and Sales Area

Table 23. Players Filgrastim Injection Products Offered

Table 24. Filgrastim Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Filgrastim Injection Sales by Geographic Region (2017-2022) & (KL)

Table 28. Global Filgrastim Injection Sales Market Share Geographic Region (2017-2022)

Table 29. Global Filgrastim Injection Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Filgrastim Injection Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Filgrastim Injection Sales by Country/Region (2017-2022) & (KL)

Table 32. Global Filgrastim Injection Sales Market Share by Country/Region (2017-2022)

Table 33. Global Filgrastim Injection Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Filgrastim Injection Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Filgrastim Injection Sales by Country (2017-2022) & (KL)

Table 36. Americas Filgrastim Injection Sales Market Share by Country (2017-2022)

Table 37. Americas Filgrastim Injection Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Filgrastim Injection Revenue Market Share by Country (2017-2022)

Table 39. Americas Filgrastim Injection Sales by Type (2017-2022) & (KL)

Table 40. Americas Filgrastim Injection Sales Market Share by Type (2017-2022)

Table 41. Americas Filgrastim Injection Sales by Application (2017-2022) & (KL)

Table 42. Americas Filgrastim Injection Sales Market Share by Application (2017-2022)

Table 43. APAC Filgrastim Injection Sales by Region (2017-2022) & (KL)

Table 44. APAC Filgrastim Injection Sales Market Share by Region (2017-2022)

Table 45. APAC Filgrastim Injection Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Filgrastim Injection Revenue Market Share by Region (2017-2022)

Table 47. APAC Filgrastim Injection Sales by Type (2017-2022) & (KL)

Table 48. APAC Filgrastim Injection Sales Market Share by Type (2017-2022)

Table 49. APAC Filgrastim Injection Sales by Application (2017-2022) & (KL)

Table 50. APAC Filgrastim Injection Sales Market Share by Application (2017-2022)

Table 51. Europe Filgrastim Injection Sales by Country (2017-2022) & (KL)

Table 52. Europe Filgrastim Injection Sales Market Share by Country (2017-2022)

Table 53. Europe Filgrastim Injection Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Filgrastim Injection Revenue Market Share by Country (2017-2022)

Table 55. Europe Filgrastim Injection Sales by Type (2017-2022) & (KL)

Table 56. Europe Filgrastim Injection Sales Market Share by Type (2017-2022)

Table 57. Europe Filgrastim Injection Sales by Application (2017-2022) & (KL)

Table 58. Europe Filgrastim Injection Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Filgrastim Injection Sales by Country (2017-2022) & (KL)

Table 60. Middle East & Africa Filgrastim Injection Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Filgrastim Injection Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Filgrastim Injection Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Filgrastim Injection Sales by Type (2017-2022) & (KL)

Table 64. Middle East & Africa Filgrastim Injection Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Filgrastim Injection Sales by Application (2017-2022) & (KL)

Table 66. Middle East & Africa Filgrastim Injection Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Filgrastim Injection

Table 68. Key Market Challenges & Risks of Filgrastim Injection

Table 69. Key Industry Trends of Filgrastim Injection

Table 70. Filgrastim Injection Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Filgrastim Injection Distributors List

Table 73. Filgrastim Injection Customer List

Table 74. Global Filgrastim Injection Sales Forecast by Region (2023-2028) & (KL)

Table 75. Global Filgrastim Injection Sales Market Forecast by Region

Table 76. Global Filgrastim Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Filgrastim Injection Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Filgrastim Injection Sales Forecast by Country (2023-2028) & (KL)

Table 79. Americas Filgrastim Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Filgrastim Injection Sales Forecast by Region (2023-2028) & (KL)

Table 81. APAC Filgrastim Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Filgrastim Injection Sales Forecast by Country (2023-2028) & (KL)

Table 83. Europe Filgrastim Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Filgrastim Injection Sales Forecast by Country (2023-2028) & (KL)

Table 85. Middle East & Africa Filgrastim Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Filgrastim Injection Sales Forecast by Type (2023-2028) & (KL)

Table 87. Global Filgrastim Injection Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Filgrastim Injection Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Filgrastim Injection Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Filgrastim Injection Sales Forecast by Application (2023-2028) & (KL)

Table 91. Global Filgrastim Injection Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Filgrastim Injection Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Filgrastim Injection Revenue Market Share Forecast by Application (2023-2028)

Table 94. Accord Healthcare Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors

Table 95. Accord Healthcare Filgrastim Injection Product Offered

Table 96. Accord Healthcare Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 97. Accord Healthcare Main Business

Table 98. Accord Healthcare Latest Developments

Table 99. Teva Pharmaceuticals Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors

Table 100. Teva Pharmaceuticals Filgrastim Injection Product Offered

Table 101. Teva Pharmaceuticals Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 102. Teva Pharmaceuticals Main Business

Table 103. Teva Pharmaceuticals Latest Developments

Table 104. Pfizer Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors

Table 105. Pfizer Filgrastim Injection Product Offered

Table 106. Pfizer Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 107. Pfizer Main Business

Table 108. Pfizer Latest Developments

Table 109. Amgen Inc Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors

Table 110. Amgen Inc Filgrastim Injection Product Offered

Table 111. Amgen Inc Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 112. Amgen Inc Main Business

Table 113. Amgen Inc Latest Developments

Table 114. Novartis AG Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors

Table 115. Novartis AG Filgrastim Injection Product Offered

Table 116. Novartis AG Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 117. Novartis AG Main Business

Table 118. Novartis AG Latest Developments

List of Figures

Figure 1. Picture of Filgrastim Injection

Figure 2. Filgrastim Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Filgrastim Injection Sales Growth Rate 2017-2028 (KL)

Figure 7. Global Filgrastim Injection Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Filgrastim Injection Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 300mcg/mL (vial)

Figure 10. Product Picture of 480mcg/1.6 mL (vial)

Figure 11. Product Picture of 300mcg/0.5mL (Prefilled Syringe)

Figure 12. Product Picture of 480mcg/0.8mL (Prefilled Syringe)

Figure 13. Global Filgrastim Injection Sales Market Share by Type in 2021

Figure 14. Global Filgrastim Injection Revenue Market Share by Type (2017-2022)

Figure 15. Filgrastim Injection Consumed in Adult Use

Figure 16. Global Filgrastim Injection Market: Adult Use (2017-2022) & (KL)

Figure 17. Filgrastim Injection Consumed in Pediatric Use

Figure 18. Global Filgrastim Injection Market: Pediatric Use (2017-2022) & (KL)

Figure 19. Filgrastim Injection Consumed in Geriatric Use

Figure 20. Global Filgrastim Injection Market: Geriatric Use (2017-2022) & (KL)

Figure 21. Global Filgrastim Injection Sales Market Share by Application (2017-2022)

Figure 22. Global Filgrastim Injection Revenue Market Share by Application in 2021

Figure 23. Filgrastim Injection Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Filgrastim Injection Revenue Market Share by Company in 2021

Figure 25. Global Filgrastim Injection Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Filgrastim Injection Revenue Market Share by Geographic Region in 2021

Figure 27. Global Filgrastim Injection Sales Market Share by Region (2017-2022)

Figure 28. Global Filgrastim Injection Revenue Market Share by Country/Region in 2021

Figure 29. Americas Filgrastim Injection Sales 2017-2022 (KL)

Figure 30. Americas Filgrastim Injection Revenue 2017-2022 ($ Millions)

Figure 31. APAC Filgrastim Injection Sales 2017-2022 (KL)

Figure 32. APAC Filgrastim Injection Revenue 2017-2022 ($ Millions)

Figure 33. Europe Filgrastim Injection Sales 2017-2022 (KL)

Figure 34. Europe Filgrastim Injection Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Filgrastim Injection Sales 2017-2022 (KL)

Figure 36. Middle East & Africa Filgrastim Injection Revenue 2017-2022 ($ Millions)

Figure 37. Americas Filgrastim Injection Sales Market Share by Country in 2021

Figure 38. Americas Filgrastim Injection Revenue Market Share by Country in 2021

Figure 39. United States Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Filgrastim Injection Sales Market Share by Region in 2021

Figure 44. APAC Filgrastim Injection Revenue Market Share by Regions in 2021

Figure 45. China Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Filgrastim Injection Sales Market Share by Country in 2021

Figure 52. Europe Filgrastim Injection Revenue Market Share by Country in 2021

Figure 53. Germany Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Filgrastim Injection Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Filgrastim Injection Revenue Market Share by Country in 2021

Figure 60. Egypt Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Filgrastim Injection Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Filgrastim Injection in 2021

Figure 66. Manufacturing Process Analysis of Filgrastim Injection

Figure 67. Industry Chain Structure of Filgrastim Injection

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390